Showing results (111-120 of 237) with videos related to
Sort By:
Pageof 24
Cancer Medicine|December 20, 2018
The prognostic significance of circulating tumor cells in head and neck and non-small-cell lung cancerArutha Kulasinghe, Joanna Kapeleris, Rebecca Kimberley, et al.Human Pathology|December 3, 2014
The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusionsBen Davidson, Arild Holth, Ellen Hellesylt, et al.Science Advances|July 26, 2016
Liquid biopsy and therapeutic response: Circulating tumor cell cultures for evaluation of anticancer treatmentBee Luan Khoo, Gianluca Grenci, Tengyang Jing, et al.Plos One|December 22, 2021
Extracellular domains of E-cadherin determine key mechanical phenotypes of an epithelium through cell- and non-cell-autonomous outside-in signalingDarwesh Mohideen Kaderbatcha Aladin, Yeh Shiu Chu, Shuo Shen, et al.International Journal of Medical Sciences|December 4, 2024
Co-inhibition of PGF and VEGFA enhances the effectiveness of immunotherapy in bladder cancerXianzhi Yang, Haoxiang Zheng, Jianxu Huang, et al.Journal De La Societe De Biologie|December 8, 2006
[Mammary gland development: Role of basal myoepithelial cells]Marisa M Faraldo, Ilaria Taddei-De La Hosseraye, Jérôme Teulière, et al.Science Signaling|October 6, 2016
The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancerJane Antony, Tuan Zea Tan, Zoe Kelly, et al.Nature Cell Biology|May 13, 2008
Beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cellsIlaria Taddei, Marie-Ange Deugnier, Marisa M Faraldo, et al.Oncoimmunology|February 16, 2017
The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200Muhammad Zaeem Noman, Bassam Janji, Abderemane Abdou, et al.Oncogene|November 2, 2004
Inhibition of human bladder tumour cell growth by fibroblast growth factor receptor 2b is independent of its kinase activity. Involvement of the carboxy-terminal region of the receptorIsabelle Bernard-Pierrot, David Ricol, Andrew Cassidy, et al.Pageof 24